Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Michelle Petri

ResearcherPublications, citations & collaboration network

Michelle Petri is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 968 works, 75,786 citations, an h-index of 137 and an i10-index of 565.

968
Works
75,786
Citations
137
h-index
565
i10-index

How has Michelle Petri's publication output changed over time?

ScholarIQpublication output · 1997–2023

Output grew0% over the shown period — from 1 works in 1997 to 1 in 2023.

1
3
1
1
2
1
1
1
1
199720052006200820112012201820192023

What are the most-cited papers on Michelle Petri?

ScholarIQmost cited works
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Michelle Petri, Ana‐Maria Orbai, Graciela S. Alarcón, Caroline Gordon, Joan T. Merrill, Paul R. Fortin, Ian N Bruce, David Isenberg, Daniel J. Wallace, Ola Nived, Gunnar Sturfelt, Rosalind Ramsey‐Goldman, Sang‐Cheol Bae, John G. Hanly, Jorge Sánchez‐Guerrero, Ann E. Clarke, Cynthia Aranow, Susan Manzi, Murray Urowitz, Dafna D. Gladman, Kenneth Kalunian, Melissa Costner, Victoria P. Werth, Asad Zoma, Sasha Bernatsky, Guillermo Ruiz‐Irastorza, Munther A. Khamashta, Søren Jacobsen, Jill P. Buyon, Peter J. Maddison, Mary Anne Dooley, Ronald van Vollenhoven, Ellen M. Ginzler, Thomas Stoll, Christine Peschken, Joseph L. Jorizzo, Jeffrey P. Callen, S. Sam Lim, Barri J. Fessler, Murat İnanç, Diane L. Kamen, Anisur Rahman, Kristján Steinsson, Andrew G. Franks, Lisa Sigler, Suhail Hameed, Hong Fang, Ngoc Minh Pham, Robin L. Brey, Michael H. Weisman, Gerald McGwin, Laurence S. Magder
S132787887. 20125,341 CitationsOPEN ACCESS
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra Navarra, Renato Guzmán, A Gallacher, Stephen Hall, Roger A. Levy, Renato Jimenez, Edmund KM Li, Mathew Thomas, Ho‐Youn Kim, Manuel Gustavo Leon, C Tănăsescu, Е. Л. Насонов, Joung-Liang Lan, Lilia Pineda, Z. John Zhong, William W. Freimuth, Michelle Petri
The Lancet. 20112,071 Citations
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J. Wallace, Dana Tegzová, Jorge Sánchez‐Guerrero, Andreas Schwarting, Joan T. Merrill, Winn Chatham, William Stohl, Ellen M. Ginzler, Douglas R. Hough, Z. John Zhong, William W. Freimuth, Ronald van Vollenhoven, BLISS-76 Study Group
S132787887. 20111,675 CitationsOPEN ACCESS
Mortality in systemic lupus erythematosus
Sasha Bernatsky, J.‐F. Boivin, L. Joseph, S Manzi, Ellen M. Ginzler, Dafna D. Gladman, Murray B. Urowitz, Paul R. Fortin, Michelle Petri, Susan G. Barr, Caroline Gordon, Sang‐Cheol Bae, David Isenberg, Asad Zoma, Cynthia Aranow, Mary Anne Dooley, Ola Nived, Gunnar Sturfelt, K Steinsson, Graciela S. Alarcón, Jean‐Luc Senécal, Michel Zummer, JG Hanly, Stephanie Ensworth, Janet Pope, Steven M. Edworthy, Anisur Rahman, John Sibley, Hani El‐Gabalawy, T McCarthy, Y. St. Pierre, Ann E. Clarke, Rosalind Ramsey‐Goldman
S132787887. 20061,192 CitationsOPEN ACCESS
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus
Michelle Petri, Mimi Kim, Kenneth Kalunian, Jennifer Grossman, Bevra H. Hahn, Lisa R. Sammaritano, Michael D. Lockshin, Joan T. Merrill, H. Michael Belmont, Anca Askanase, W. Joseph McCune, Michelene Hearth-Holmes, Mary Anne Dooley, Joan Von Feldt, Alan Friedman, M Tan, John C. Davis, Mary E. Cronin, Betty Diamond, Meggan Mackay, Lisa Sigler, Michael Fillius, Ann Rupel, Frederick Licciardi, Jill P. Buyon
New England Journal of Medicine. 20051,169 CitationsOPEN ACCESS

Related on ScholarIQ

Johns Hopkins University
Institution
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Paper
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Paper
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Paper
Mortality in systemic lupus erythematosus
Paper
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus
Paper
470M+ articles · free account